Research shows weight-loss drugs may also reduce cancer risk

Live updates

1. 8d ago

   GLP-1 Weight-Loss Drugs Linked to Taste and Smell Disorders

   Doctors are tracking a rare increase in taste and smell disorders among users of GLP-1 receptor agonists. These medications, which include Ozempic and Wegovy, are used for type 2 diabetes and weight management. While previous research focused on their ability to reduce cancer risk through weight loss, current observations highlight new sensory side effects. Medicare continues to cover these drugs at a monthly cost of $50, though medical guidance requires older adults to check for drug interactions before beginning treatment.

   Why it matters

   GLP-1 drugs mimic hormones that target appetite and blood sugar. Their widespread use for obesity has led researchers to investigate secondary health benefits and unexpected adverse reactions.

   Still unconfirmed

   • Doctors are tracking a rare rise in smell and taste disorders among GLP-1 users.

   What to watch next

   • Clinical data confirming the prevalence and cause of sensory disorders in GLP-1 patients
   • Peer-reviewed studies on the link between GLP-1 use and cancer risk reduction
   Sources used for this update (6)

   1. okdiario.com — New findings suggest diabetes and dementia are linked more closely than you think, and it could change how you protect your brain
   2. okdiario.com — Your weight-loss injection might do more than shrink your appetite: doctors are now tracking a strange rise in smell and taste problems
   3. www.theage.com.au — Can testosterone improve your sex life and boost your mood – and what are the risks? Here’s what the science says
   4. www.news-medical.net — Traditional Japanese medicine for obesity may help reduce age-related tissue fibrosis
   5. consent.yahoo.com — Can MMA Fighters Taking Psychedelics Unlock the Future of Brain Health? These Researchers Think So.
   6. www.aol.com — Dietitians Explain the Benefits of Tart Cherry Juice
   confidence 80%
2. 11d ago

   Medicare expands coverage for select GLP-1 weight-loss drugs

   Medicare now covers specific weight-loss medications for a monthly cost of $50. These GLP-1 receptor agonists, which include Wegovy and Ozempic, are used for weight management and type 2 diabetes. While researchers examine their potential to reduce cancer risk through weight loss, medical guidance emphasizes that older adults must evaluate drug interactions and side effects before starting treatment.

   Why it matters

   GLP-1 medications are used by one-in-eight American adults. The medical community is currently investigating whether these drugs can prevent or treat specific cancers.

   Still unconfirmed

   • GLP-1 drugs may have an emerging side effect affecting users on an emotional level

   What to watch next

   • Clinical trial results regarding GLP-1 efficacy in treating specific cancers
   • Updated Medicare guidelines on eligible GLP-1 medications for seniors
   Sources used for this update (7)

   1. www.medindia.net — Can Obesity Make Your Brain Age Faster? New Study Reveals a Possible Link
   2. www.thetechedvocate.org — Hair-Raising Truth: The Unexpected GLP-1 Drug Side Effect No One Saw Coming
   3. www.medindia.net — Does Your Heart Have a 'Little Brain' That Protects You During Stress?
   4. www.aarp.org — Medicare Now Covers Some Weight Loss Drugs — but Older Adults Should Weigh the Risks
   5. stmdailynews.com — Is Vaping Really Safer Than Smoking? Here’s What You Should Know
   6. www.myjoyonline.com — Daily habits that help and hurt your Liver
   7. www.aol.com — Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer
   confidence 80%
3. 14d ago

   Weight-loss drugs and cancer risk research continues

   Researchers are investigating if GLP-1 receptor agonists like Wegovy and Ozempic can prevent or treat specific cancers. Data indicates a connection between substantial weight loss and a decrease in cancer risk. One-in-eight American adults use these medications.

   Sources used for this update (4)

   1. The best and worst diet and lifestyle habits for your liver
   2. GLP-1 meds now covered by Medicare — with some restrictions
   3. Yo-Yo dieting could quietly harm your muscles, study suggests
   4. Genetic factors influence cholesterol response to low-carb diets
   confidence 80%
4. 40d ago

   GLP-1 Weight-Loss Drugs Linked to Cancer Prevention and Treatment

   Researchers are studying whether GLP-1 receptor agonists like Ozempic and Wegovy can treat or prevent certain cancers. These medications are currently used by one-in-eight American adults. New data suggests a link between significant weight loss and lower cancer risk.

   What's confirmed:

   • GLP-1 receptor agonists such as Ozempic and Wegovy may help treat or prevent certain cancers.
   • Researchers are investigating if medications like Ozempic, Mounjaro, and Wegovy can treat or prevent arthritis.
   • GLP-1 medications help manage blood sugar and improve heart health.

   Still unconfirmed:

   • One-in-eight American adults now take GLP-1s.
   • Weight-loss drugs could potentially help people live longer.
   • Kathy Bates lost 100 pounds over seven years using Ozempic and lifestyle changes.
   Sources used for this update (9)

   1. Health News: Latest Research, Top Stories, Trending Topics
   2. Can GLP-1s Treat Cancer? What the Latest Science Says About ... - WTOP
   3. 'Matlock' Actress Kathy Bates Lost 100 Pounds After Two Cancer ...
   4. What effects do GLP-1s have on cancer? | WYPR
   5. Could Weight Loss Drugs Also Be Longevity Drugs? Here's What New ...
   6. Could GLP-1 Weight Loss Drugs Also Treat or Prevent Chronic Diseases?
   7. What effects do GLP-1s have on cancer? | WCMU Public Media
   8. As weight loss drugs like Ozempic spread, Louisiana doctors ...
   9. Research shows weight-loss drugs may also reduce cancer risk
   confidence 80%
5. 45d ago

   GLP-1 Drugs Linked to Lower Cancer Risk and Slower Progression

   Early research suggests GLP-1 medications like Ozempic and Mounjaro can reduce the odds of developing certain cancers. Data indicates these drugs may also slow the spread of obesity-related cancers. Experts state that more research is required to confirm these findings.

   What's confirmed:

   • GLP-1 drugs including Ozempic, Wegovy, Mounjaro, and Zepbound may lower the risk of developing certain cancers.
   • Research suggests these medications may slow cancer progression in some patients.

   Still unconfirmed:

   • GLP-1 receptor agonists may reduce metastatic progression specifically in lung, breast, colorectal, and liver cancers.
   Sources used for this update (6)

   1. Can GLP-1 Drugs Lower Cancer Risk? - Obesity - Everyday Health
   2. GLP-1 RAs May Reduce Metastatic Progression in Certain Obesity-Related ...
   3. GLP-1 drugs and colorectal cancer prevention
   4. How Weight-Loss Drugs May Reduce Cancer Risk - World Today Journal
   5. The New Cancer Question at ASCO 2026: Can GLP-1 Drugs Reduce Cancer ...
   6. Can GLP-1 Drugs Lower Cancer Risks? - Healthesystems
   confidence 80%
6. 49d ago

   GLP-1 Weight-Loss Drugs Linked to Lower Cancer Risks

   Research indicates GLP-1 medications like Ozempic and Wegovy may reduce the risk of several obesity-related cancers. Studies show significant risk reductions for colorectal, pancreatic, and breast cancers. Some data suggests these drugs may also improve survival rates and slow cancer progression.

   What's confirmed:

   • GLP-1 medications are linked to a decreased risk of obesity-related cancers, including colorectal, pancreatic, and endometrial types.
   • Women taking GLP-1 drugs had a lower risk of breast cancer in a study of more than 110,000 women.
   • GLP-1 drugs are associated with a 30% lower risk of breast cancer in women.
   • The American Society of Clinical Oncology reports that GLP-1 medications may help prevent cancer.

   Still unconfirmed:

   • GLP-1 RA use is linked to improved survival in patients with cancer.
   Sources used for this update (19)

   1. GLP-1 drugs linked to major drop in pancreatic, colorectal cancer risk
   2. Weight loss drugs slash risk of 4 types of cancer by 50% or more, study finds
   3. Breast Imaging in Focus: Can GLP-1 Receptor Agonists Reduce Breast Cancer Risk? What New Research Reveals
   4. GLP-1s Tied to Lower Cancer Risk in Patients With Obesity
   5. Ontada Analysis Finds GLP-1 RA Use Linked to Improved Survival in Patients With Cancer
   6. Research shows weight-loss drugs may also reduce cancer risk
   7. ASCO 2026 | GLP-1 receptor agonist use linked to lower breast cancer incidence
   8. Study: GLP-1 weight loss drugs tied to 30% lower breast cancer risk in women
   9. Should everyone be on GLP-1s? What the science really tells us about cancer prevention and other benefits
   10. Exploring the Weight Loss Potential of GLP-1 Agonists in Patients With Breast Cancer
   11. Research shows GLP-1 medications may help reduce cancer risk
   12. GLP-1 weight loss drugs are being linked to lower breast cancer risk. Experts...
   confidence 90%